Metastatic Renal Cell Carcinoma Presenting as a Rapidly Enlarging Endotracheal Mass Due to Hyperprogression on Anti-PD1 Immunotherapy

Ear Nose Throat J. 2021 Dec;100(10_suppl):905S-907S. doi: 10.1177/0145561320931215. Epub 2020 May 29.

Authors

Steven G Hoshal¹, Peter C Wickwire¹, Regina F Gandour-Edwards², Prabhu Rajappa³, Daniel J Cates^{1

3}

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, University of California, Davis, Sacramento, CA, USA.
² Department of Pathology and Laboratory Medicine, University of California, Davis, Sacramento, CA, USA.
³ Department of Veterans Affairs, Northern California Healthcare System, Mather, CA, USA.

PMID: 32466731
DOI: 10.1177/0145561320931215

No abstract available

Keywords: bronchoscopy; immunotherapy; renal cell carcinoma; trachea; tumor.

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Bronchoscopy
Carcinoma, Renal Cell / drug therapy
Carcinoma, Renal Cell / secondary*
Carcinoma, Renal Cell / surgery
Disease Progression
Humans
Kidney Neoplasms / pathology*
Male
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Respiratory Insufficiency / etiology
Respiratory Insufficiency / surgery
Tracheal Neoplasms / drug therapy
Tracheal Neoplasms / secondary*
Tracheal Neoplasms / surgery

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Programmed Cell Death 1 Receptor
pembrolizumab